Pinnacle Wealth Planning Services, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Pinnacle Wealth Planning Services, Inc.

  • $733 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 02, 2021
SELL
$92.19 - $115.71 $168,338 - $211,286
-1,826 Closed
0 $0
Q1 2021

Apr 29, 2021
SELL
$106.9 - $167.73 $748 - $1,174
-7 Reduced 0.38%
1,826 $208,000
Q4 2020

Feb 12, 2021
BUY
$84.4 - $177.39 $154,705 - $325,155
1,833 New
1,833 $254,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.1B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Pinnacle Wealth Planning Services, Inc. Portfolio

Follow Pinnacle Wealth Planning Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email